BR0315106A - Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica - Google Patents

Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica

Info

Publication number
BR0315106A
BR0315106A BR0315106-9A BR0315106A BR0315106A BR 0315106 A BR0315106 A BR 0315106A BR 0315106 A BR0315106 A BR 0315106A BR 0315106 A BR0315106 A BR 0315106A
Authority
BR
Brazil
Prior art keywords
oxazolidinone
derivatives
bicyclic
processes
antimicrobial derivatives
Prior art date
Application number
BR0315106-9A
Other languages
English (en)
Inventor
Mikhail Fedor Gordeev
Adam Renslo
Dinesh Vinoobhai Patel
Original Assignee
Pharmacia & Up John Company Ll
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Up John Company Ll filed Critical Pharmacia & Up John Company Ll
Publication of BR0315106A publication Critical patent/BR0315106A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"DERIVADOS ANTIMICROBIANOS DE [3.1.0]OXAZOLIDINONA BICìCLICA". A presente invenção refere-se a determinados derivados de [3.1.O]oxazolidinona bicíclica das fórmulas I e II, descritas aqui, ou sais farmaceuticamente aceitáveis ou pró-drogas dos mesmos, que são agentes antibacterianos, composições farmacêuticas contendo os mesmos, processos para seu uso e processos para preparação desses compostos.
BR0315106-9A 2002-10-09 2003-10-03 Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica BR0315106A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41773502P 2002-10-09 2002-10-09
PCT/US2003/028560 WO2004033451A1 (en) 2002-10-09 2003-10-03 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives

Publications (1)

Publication Number Publication Date
BR0315106A true BR0315106A (pt) 2005-08-09

Family

ID=32094075

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315106-9A BR0315106A (pt) 2002-10-09 2003-10-03 Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica

Country Status (10)

Country Link
US (1) US6875784B2 (pt)
EP (1) EP1549641A1 (pt)
JP (1) JP2006508934A (pt)
AR (1) AR041568A1 (pt)
AU (1) AU2003278791A1 (pt)
BR (1) BR0315106A (pt)
CA (1) CA2501352A1 (pt)
MX (1) MXPA05003780A (pt)
TW (1) TW200410961A (pt)
WO (1) WO2004033451A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2530140C (en) 2003-07-02 2010-11-09 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
EP1646630A1 (en) * 2003-07-02 2006-04-19 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
KR20090096716A (ko) * 2007-01-09 2009-09-14 바이엘 쉐링 파마 악티엔게젤샤프트 아지리딘의 플루오르화에 의한 방사성표지
EP1944288A1 (en) * 2007-01-09 2008-07-16 Bayer Schering Pharma Aktiengesellschaft Radiolabelling via fluorination of aziridines
NZ586104A (en) 2007-12-20 2012-02-24 Astrazeneca Ab Carbamoyl compounds as dgat1 inhibitors 190
WO2009090548A2 (en) * 2008-01-17 2009-07-23 Glenmark Pharmaceuticals, S.A. 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
CA2743971A1 (en) 2008-11-20 2010-05-27 Panacea Biotec Ltd. Novel antimicrobials
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
BR112013007566A2 (pt) 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
SI3143011T1 (sl) 2014-05-13 2021-08-31 F. Hoffmann-La Roche Ag Devterirane heterociklične spojine in njihova uporaba kot kontrastna sredstva
KR102511898B1 (ko) * 2015-07-17 2023-03-20 더 글로벌 얼라이언스 포 티비 드러그 디벨롭먼트, 잉크. 항미생물 요법을 위한 치환된 페닐옥사졸리디논

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183857A (en) 1978-07-06 1980-01-15 Shell Oil Company 3-Benzyl-3-azabicyclo(3.1.0)hexane-2,4-dione
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5023472A (en) * 1988-09-09 1991-06-11 Texas Instruments Incorporated Capacitor-driven signal transmission circuit
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
KR960004339A (ko) 1994-07-02 1996-02-23 임성기 신규한 퀴놀린계 화합물 및 그 의 제조방법
ATE239720T1 (de) 1995-02-02 2003-05-15 Daiichi Seiyaku Co Heterozyklische verbindungen
US6124334A (en) * 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
US6255304B1 (en) * 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
EP0984947B8 (en) 1997-05-30 2005-06-15 Pharmacia & Upjohn Company LLC Oxazolidinone antibacterial agents having a thiocarbonyl functionality
US6069141A (en) 1998-02-13 2000-05-30 Pharmacia & Upjohn Company Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
CN1311787A (zh) 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
HUP0203869A2 (hu) 1999-12-21 2003-07-28 Pharmacia & Upjohn Co. Szulfoximin funkcionalitással rendelkező oxazolidinok és alkalmazásuk mikrobaellenes szerként, a vegyületeket tartalmazó gyógyszerkészítmények
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
US6642238B2 (en) * 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20020044A1 (es) * 2000-06-16 2002-01-30 Upjohn Co Tiazina oxazolidinona
PL363960A1 (en) 2000-07-17 2004-11-29 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
CA2424402A1 (en) * 2000-12-21 2002-08-01 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
CA2443410A1 (en) 2001-04-17 2003-04-03 Yasumichi Fukuda Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
WO2004014392A1 (en) * 2002-07-29 2004-02-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
AR041568A1 (es) 2005-05-18
CA2501352A1 (en) 2004-04-22
MXPA05003780A (es) 2005-06-08
EP1549641A1 (en) 2005-07-06
WO2004033451A1 (en) 2004-04-22
US20040127530A1 (en) 2004-07-01
TW200410961A (en) 2004-07-01
AU2003278791A1 (en) 2004-05-04
US6875784B2 (en) 2005-04-05
JP2006508934A (ja) 2006-03-16

Similar Documents

Publication Publication Date Title
BR0212378A (pt) Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0313041A (pt) Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos
BR9712672A (pt) Derivados heterocìclicos que inibem o fator xa
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
BRPI0412291A (pt) antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
BRPI0413469A (pt) derivados de piperazina para o tratamento de infecções por hiv
BR0109235A (pt) Derivados do ácido carboxìlico como antagonistas ip
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BRPI0515885A (pt) derivados de ftalazinona, sua preparação e uso como agentes farmacêuticos
BR0010938A (pt) Derivados da 13-metil eritromicina
BRPI0508107A (pt) derivados de indazol e composições farmacêuticas contendo os mesmos
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BRPI0515860B8 (pt) derivados de tetralin e indano, seus usos, e composição farmacêutica
BRPI0408437A (pt) derivados de p-diaminobenzeno substituìdos, composição farmacêutica, e, uso da mesma
BR0210028A (pt) Agentes antibacterianos
BR0212069A (pt) Agentes antidiabéticos orais
BR0315106A (pt) Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0315302A (pt) Benzoxazinonas substituìdas e seus usos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.